Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Hill

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2015
Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer: Final Results of the NO16968 Randomized Controlled Phase III TrialHans-Joachim Schmoll, Josep Tabernero, Jean Maroun, et al.
Clinical Transplantation|November 17, 2010
Long-term outcome in 42 pediatric liver transplant patients with alpha 1-antitrypsin deficiency: a single-center experienceMichael G Hughes, Khalid M Khan, Angelika C Gruessner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 2004
The value of routine serum carcino-embryonic antigen measurement and computed tomography in the surveillance of patients after adjuvant chemotherapy for colorectal cancerIan Chau, Mark J Allen, David Cunningham, et al.
Clinical Colorectal Cancer|March 18, 2004
Phase III study of mitomycin-C with protracted venous infusion or circadian-timed infusion of 5-fluorouracil in advanced colorectal carcinomaTimothy J Price, Paul J Ross, Tamas Hickish, et al.
European Journal of Cancer (Oxford, England : 1990)|July 20, 2005
Longitudinal quality of life and quality adjusted survival in a randomised controlled trial comparing six months of bolus fluorouracil/leucovorin vs. twelve weeks of protracted venous infusion fluorouracil as adjuvant chemotherapy for colorectal cancerIan Chau, Andrew R Norman, David Cunningham, et al.
European Journal of Pharmacology|August 24, 2006
Aripiprazole and its human metabolite are partial agonists at the human dopamine D2 receptor, but the rodent metabolite displays antagonist propertiesMartyn D Wood, Claire Scott, Kirsten Clarke, et al.
British Journal of Haematology|March 22, 2003
Gemcitabine, cisplatin and methylprednisolone chemotherapy (GEM-P) is an effective regimen in patients with poor prognostic primary progressive or multiply relapsed Hodgkin's and non-Hodgkin's lymphomaIan Chau, Mark Harries, David Cunningham, et al.
Biomedical Physics & Engineering Express|April 14, 2025
A survey of dosimetry quality assurance practice at UK small animal radiation research platform (SARRP) facilitiesEmma R Biglin, Ileana Silvestre Patallo, Anna Morris, et al.
The British Journal of Radiology|August 16, 2016
MRI-guided radiotherapy of the SK-N-SH neuroblastoma xenograft model using a small animal radiation research platformAurélien Corroyer-Dulmont, Nadia Falzone, Veerle Kersemans, et al.
JAMA Internal Medicine|December 6, 2016
Efficacy of Oral Risperidone, Haloperidol, or Placebo for Symptoms of Delirium Among Patients in Palliative Care: A Randomized Clinical TrialMeera R Agar, Peter G Lawlor, Stephen Quinn, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2015
Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer: Final Results of the NO16968 Randomized Controlled Phase III TrialHans-Joachim Schmoll, Josep Tabernero, Jean Maroun, et al.
Clinical Transplantation|November 17, 2010
Long-term outcome in 42 pediatric liver transplant patients with alpha 1-antitrypsin deficiency: a single-center experienceMichael G Hughes, Khalid M Khan, Angelika C Gruessner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 2004
The value of routine serum carcino-embryonic antigen measurement and computed tomography in the surveillance of patients after adjuvant chemotherapy for colorectal cancerIan Chau, Mark J Allen, David Cunningham, et al.
Clinical Colorectal Cancer|March 18, 2004
Phase III study of mitomycin-C with protracted venous infusion or circadian-timed infusion of 5-fluorouracil in advanced colorectal carcinomaTimothy J Price, Paul J Ross, Tamas Hickish, et al.
European Journal of Cancer (Oxford, England : 1990)|July 20, 2005
Longitudinal quality of life and quality adjusted survival in a randomised controlled trial comparing six months of bolus fluorouracil/leucovorin vs. twelve weeks of protracted venous infusion fluorouracil as adjuvant chemotherapy for colorectal cancerIan Chau, Andrew R Norman, David Cunningham, et al.
European Journal of Pharmacology|August 24, 2006
Aripiprazole and its human metabolite are partial agonists at the human dopamine D2 receptor, but the rodent metabolite displays antagonist propertiesMartyn D Wood, Claire Scott, Kirsten Clarke, et al.
British Journal of Haematology|March 22, 2003
Gemcitabine, cisplatin and methylprednisolone chemotherapy (GEM-P) is an effective regimen in patients with poor prognostic primary progressive or multiply relapsed Hodgkin's and non-Hodgkin's lymphomaIan Chau, Mark Harries, David Cunningham, et al.
Biomedical Physics & Engineering Express|April 14, 2025
A survey of dosimetry quality assurance practice at UK small animal radiation research platform (SARRP) facilitiesEmma R Biglin, Ileana Silvestre Patallo, Anna Morris, et al.
The British Journal of Radiology|August 16, 2016
MRI-guided radiotherapy of the SK-N-SH neuroblastoma xenograft model using a small animal radiation research platformAurélien Corroyer-Dulmont, Nadia Falzone, Veerle Kersemans, et al.
JAMA Internal Medicine|December 6, 2016
Efficacy of Oral Risperidone, Haloperidol, or Placebo for Symptoms of Delirium Among Patients in Palliative Care: A Randomized Clinical TrialMeera R Agar, Peter G Lawlor, Stephen Quinn, et al.
Pageof 6